Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CymaBay Therapeutics Inc (NASDAQ:CBAY)

7.88
Delayed Data
As of 4:00pm ET
 -0.26 / -3.19%
Today’s Change
1.15
Today|||52-Week Range
9.20
+355.49%
Year-to-Date
No recent news for CymaBay Therapeutics Inc.

Today’s Trading

Previous close8.14
Today’s open8.15
Day’s range7.75 - 8.16
Volume585,665
Average volume (3 months)1,042,300
Market cap$356.2M
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-37.35%
Earnings growth (this year)+33.11%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book48.48

Competitors

 Today’s
change
Today’s
% change
ACETAceto Corp-0.35-3.11%
DITAMCON Distributing C...0.000.00%
AGXArgan Inc-1.15-1.70%
NUSNU Skin Enterprises ...-0.04-0.06%
Data as of 4:02pm ET, 10/23/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$26.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Sujal Shah
Chief Scientific Officer &
Senior Vice President
Charles A. McWherter
Corporate headquarters
Newark, California

Forecasts